GleamWall
中文EN

FCHS First Choice Healthcare Solutions, Inc.

Services-Medical Laboratories · OTC · SEC CIK 1416876 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-552.3%
TTM EPS YoY-518.2%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-729.6%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets657.7%
Debt / equity—
Current ratio0.01x
Interest coverage-0.14x

Cash quality & payout

Operating cash flow / net income0.12x
Accruals ratio-645.6%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue————————
Gross profit———$1,664$230$1,423$4,033—
SG&A expense$519,887$439,176$629,082$497,130$210,528$432,259$476,828-$168,343
Operating income-$690,372-$535,978-$731,332-$890,999-$621,161-$574,414-$584,456$136,483
Interest expense$9.98M$6.68M$704,389$2.57M$841,724$515,534$785,896$883,716
Pretax income-$10.68M-$7.01M-$1.44M-$3.46M-$1.46M-$639,436-$1.40M$148,718
Net income-$10.68M-$7.01M-$1.44M-$3.46M-$1.46M-$639,436-$1.40M$36,768
EBITDA-$687,466-$533,071-$728,426-$887,308-$617,058-$570,311-$578,826$145,087
EPS (basic)-0.32-0.21-0.04—-0.04-0.02-0.04—
EPS (diluted)-0.32-0.21-0.04—-0.04-0.02-0.04—
Weighted avg. shares (diluted)32.96M32.96M32.96M—32.96M32.96M32.96M—
Balance sheet
Cash & equivalents$135,212$6,842$3,859$5,896$2,430$6,454$29,645$19,915
Receivables$37,611$403$40,575$717$1,173$9,459$40,287$72,270
Current assets$172,823$7,245$44,434$6,613$3,603$15,913$69,932$92,185
PP&E, net$59,118$141,148$144,055$146,961$150,653$154,756$179,646$222,816
Total assets$2.08M$576,493$4.05M$4.05M$4.11M$4.22M$4.40M$4.51M
Current liabilities$13.68M$10.08M$42.23M$40.67M$37.16M$35.69M$34.64M$33.27M
Total liabilities$13.68M$10.08M$45.04M$43.58M$40.16M$38.78M$38.29M$36.98M
Shareholders' equity-$11.60M-$9.51M-$40.99M-$39.53M-$36.04M-$34.56M-$33.89M-$32.47M
Shares outstanding32.96M32.96M32.96M32.96M32.96M32.96M32.96M32.96M
Cash flow statement
Operating cash flow-$2.42M$142,984-$327,038$3,466-$163,570-$96,884-$292,031-$2.39M
Investing cash flow———$0$0$0$10,000$1.65M
Financing cash flow$2.55M-$140,000$325,000$0$159,546$73,694$291,760$764,445
Depreciation & amortization$2,906$2,907$2,906$3,691$4,103$4,103$5,630$8,604

Free plan shows the latest 8 periods; Pro shows all 50 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.